Clinical research on priming regimen CAG in treatment of acute myeloid leukemia in elderly
10.3760/cma.j.issn.1008-6706.2011.17.014
- VernacularTitle:预激方案治疗老年人急性髓性白血病的临床研究
- Author:
Zunchang LI
;
Hongjie FU
;
Mingdong SUN
;
Honghua YIN
;
Sheng YANG
- Publication Type:Journal Article
- Keywords:
Antineoplastic combined chemotherapy protocols;
Leukemia,myeloid;
Aged
- From:
Chinese Journal of Primary Medicine and Pharmacy
2011;18(17):2331-2332
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the effect and adverse reaction of priming regimen CAG in treatment of acute myeloid leukemia in elderly.Methods 32 elderly patients with acute myelogenous leukemia were treated with CAG regimen and 25 cases with standard chemotherapy regimen( DA regimen). The effect and adverse reaction were compared between the two groups. Results There was no significant difference of the complete remission rate and effective rate between the two groups. The recovery time of bone marrow and death rate of CAG the regimen group were superior to those of the DA group. Conclusion CAG regimen was effctive and safe for elderly patients with acute myeloid leukemia.